|
VAPA expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.22410000000539E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.776400E-04 |
| Normal-vs-Stage2 |
2.041600E-03 |
| Normal-vs-Stage3 |
5.96119999999312E-05 |
| Normal-vs-Stage4 |
4.43930000000314E-05 |
| Stage1-vs-Stage2 |
6.035800E-01 |
| Stage1-vs-Stage3 |
2.245800E-01 |
| Stage1-vs-Stage4 |
9.268400E-02 |
| Stage2-vs-Stage3 |
7.196800E-01 |
| Stage2-vs-Stage4 |
4.549000E-01 |
| Stage3-vs-Stage4 |
6.522600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.10119999999314E-05 |
| Normal-vs-AfricanAmerican |
3.560400E-01 |
| Normal-vs-Asian |
1.217790E-04 |
| Caucasian-vs-AfricanAmerican |
5.677800E-02 |
| Caucasian-vs-Asian |
5.219800E-01 |
| AfricanAmerican-vs-Asian |
5.967600E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.21509999999148E-05 |
| Normal-vs-Female |
2.008200E-04 |
| Male-vs-Female |
3.453000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.960000E-04 |
| Normal-vs-Age(41-60Yrs) |
3.69439999999832E-05 |
| Normal-vs-Age(61-80Yrs) |
1.791930E-04 |
| Normal-vs-Age(81-100Yrs) |
1.563200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.979800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.438600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.266400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.374000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.016800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.872600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.280800E-01 |
| Classical-VS-Follicular |
8.392000E-01 |
| Classical-VS-Other |
1.412590E-01 |
| Classical-VS-Normal |
3.422800E-04 |
| Tall-VS-Follicular |
3.926000E-01 |
| Tall-VS-Other |
3.914200E-01 |
| Tall-VS-Normal |
1.261520E-03 |
| Follicular-VS-Other |
2.427800E-01 |
| Follicular-VS-Normal |
4.482000E-03 |
| Other-VS-Normal |
1.187600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.9084000000007E-05 |
| Normal-vs-N1 |
1.68944999999754E-05 |
| N0-vs-N1 |
1.473590E-01 |
|
|
